{
    "organizations": [],
    "uuid": "6fff597dc8f774938bea871a8eb939cd88151df5",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/03/05/globe-newswire-opgen-announces-date-of-fourth-quarter-and-fiscal-year-2017-financial-results-conference-call.html",
    "ord_in_thread": 0,
    "title": "OpGen Announces Date of Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "GAITHERSBURG, Md., OpGen, Inc. (NASDAQ:OPGN) announced today that the Company will report its fourth quarter and fiscal year 2017 financial results after close of market on Thursday, March 15, 2018. OpGen’s management team will host a live conference call and webcast at 4:30 p.m. Eastern time to discuss the Company’s financial results and business progress.\nDial-in Information\nU.S. Dial-In Number: (888) 883-4599\nInternational Dial-In Number: (484) 653-6821\nConference ID: 8899787\nReplay Dial-in Information\nU.S. Dial-In Number: (855) 859-2056\nInternational Dial-In Number: (404) 537-3406\nConference ID: 8899787\nFollowing the conclusion of the conference call, a replay will be available through March 22, 2018. The live, listen-only webcast of the conference call may also be accessed by visiting the investors section of the Company’s website at http://ir.opgen.com . A replay of the webcast will be available after the conclusion of the call and will be archived on the Company’s website for 90 days.\nAbout OpGen\nOpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection treatment and prevention. Learn more at www.opgen.com and follow OpGen on Twitter and LinkedIn.\nOpGen, Acuitas, and Acuitas Lighthouse are registered trademarks of OpGen, Inc. All other trademarks are properties of their respective owners.\nOpGen Contact:\nMichael Farmer\nSr. Director, Marketing\n240-813-1284\nmfarmer@opgen.com\nInvestorRelations@opgen.com\nInvestor Contacts:\nLHA Investor Relations\nKim Sutton Golodetz\n212-838-3777\nkgolodetz@lhai.com\nor\nBruce Voss\n310-691-7100\nbvoss@lhai.com\nSource:OpGen, Inc.",
    "published": "2018-03-06T00:00:00.000+02:00",
    "crawled": "2018-03-06T01:32:14.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "gaithersburg",
        "opgen",
        "nasdaq",
        "opgn",
        "announced",
        "today",
        "company",
        "report",
        "fourth",
        "quarter",
        "fiscal",
        "year",
        "financial",
        "result",
        "close",
        "market",
        "thursday",
        "march",
        "opgen",
        "management",
        "team",
        "host",
        "live",
        "conference",
        "call",
        "webcast",
        "eastern",
        "time",
        "discus",
        "company",
        "financial",
        "result",
        "business",
        "progress",
        "information",
        "number",
        "international",
        "number",
        "conference",
        "id",
        "replay",
        "information",
        "number",
        "international",
        "number",
        "conference",
        "id",
        "following",
        "conclusion",
        "conference",
        "call",
        "replay",
        "available",
        "march",
        "live",
        "webcast",
        "conference",
        "call",
        "may",
        "also",
        "accessed",
        "visiting",
        "investor",
        "section",
        "company",
        "website",
        "http",
        "replay",
        "webcast",
        "available",
        "conclusion",
        "call",
        "archived",
        "company",
        "website",
        "day",
        "opgen",
        "opgen",
        "harnessing",
        "power",
        "informatics",
        "genomic",
        "analysis",
        "provide",
        "complete",
        "solution",
        "patient",
        "hospital",
        "infection",
        "treatment",
        "prevention",
        "learn",
        "follow",
        "opgen",
        "twitter",
        "linkedin",
        "opgen",
        "acuitas",
        "acuitas",
        "lighthouse",
        "registered",
        "trademark",
        "opgen",
        "trademark",
        "property",
        "respective",
        "owner",
        "opgen",
        "contact",
        "michael",
        "farmer",
        "director",
        "marketing",
        "mfarmer",
        "investorrelations",
        "investor",
        "contact",
        "lha",
        "investor",
        "relation",
        "kim",
        "sutton",
        "golodetz",
        "kgolodetz",
        "bruce",
        "voss",
        "bvoss",
        "source",
        "opgen",
        "inc"
    ]
}